title: Effectiveness of RSV-IG in premature infants: potential pitfalls in clinical settings.
authors.forename: M
authors.initials: M
authors.lastname: Seid
authors.forename: P S
authors.initials: PS
authors.lastname: Kurtin
authors.forename: G L
authors.initials: GL
authors.lastname: Romanowski
authors.forename: P R
authors.initials: PR
authors.lastname: Wozniak
authors.forename: S
authors.initials: S
authors.lastname: Wenger
authors.forename: S L
authors.initials: SL
authors.lastname: Segota
authors.forename: J
authors.initials: J
authors.lastname: Bradley
authors.forename: A
authors.initials: A
authors.lastname: Chan
mesh_terms: D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007223:Infant; D007234:Infant, Premature; D010352:Patient Dropouts; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D012189:Retrospective Studies; D016896:Treatment Outcome; D016312:Treatment Refusal / Q000706:statistics & numerical data*
chemical_list: D016756:Immunoglobulins, Intravenous; C098685:respiratory syncytial virus immune globulin intravenous